Trial Profile
Study of the effectiveness of voriconazole in the treatment of Aspergillus fumigatus associated asthma: a randomised double blinded, placebo controlled trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Voriconazole (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- Acronyms EVITA3
- Sponsors Pfizer
- 01 Apr 2014 Planned number of patients changed to 70.
- 01 Apr 2014 New trial record